liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Swedish guidelines on the management of community-acquired pneumonia in immunocompetent adults-Swedish Society of Infectious Diseases 2012
Karolinska University Hospital, Sweden .
Karolinska University Hospital, Sweden Örebro University Hospital, Sweden .
Östergötlands Läns Landsting, Heart and Medicine Center, Department of Infectious Diseases.
University of Uppsala Hospital, Sweden .
Show others and affiliations
2012 (English)In: Scandinavian Journal of Infectious Diseases, ISSN 0036-5548, E-ISSN 1651-1980, Vol. 44, no 12, 885-902 p.Article, review/survey (Refereed) Published
Abstract [en]

This document presents the 2012 evidence based guidelines of the Swedish Society of Infectious Diseases for the in-hospital management of adult immunocompetent patients with community-acquired pneumonia (CAP). The prognostic score CRB-65 is recommended for the initial assessment of all CAP patients, and should be regarded as an aid for decision-making concerning the level of care required, microbiological investigation, and antibiotic treatment. Due to the favourable antibiotic resistance situation in Sweden, an initial narrow-spectrum antibiotic treatment primarily directed at Streptococcus pneumoniae is recommended in most situations. The recommended treatment for patients with severe CAP (CRB-65 score 2) is penicillin G in most situations. In critically ill patients (CRB-65 score 3-4), combination therapy with cefotaxime/macrolide or penicillin G/fluoroquinolone is recommended. A thorough microbiological investigation should be undertaken in all patients, including blood cultures, respiratory tract sampling, and urine antigens, with the addition of extensive sampling for more uncommon respiratory pathogens in the case of severe disease. Recommended measures for the prevention of CAP include vaccination for influenza and pneumococci, as well as smoking cessation.

Place, publisher, year, edition, pages
Informa Healthcare , 2012. Vol. 44, no 12, 885-902 p.
Keyword [en]
CAP, pneumonia, community acquired
National Category
Engineering and Technology
Identifiers
URN: urn:nbn:se:liu:diva-86369DOI: 10.3109/00365548.2012.700120ISI: 000311127800001OAI: oai:DiVA.org:liu-86369DiVA: diva2:576909
Note

Funding Agencies|Swedish Society of Infectious Diseases||

Available from: 2012-12-14 Created: 2012-12-14 Last updated: 2017-12-06

Open Access in DiVA

No full text

Other links

Publisher's full text
By organisation
Department of Infectious Diseases
In the same journal
Scandinavian Journal of Infectious Diseases
Engineering and Technology

Search outside of DiVA

GoogleGoogle Scholar

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 69 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf